These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29568380)

  • 1. Adenosine A
    Hinz S; Navarro G; Borroto-Escuela D; Seibt BF; Ammon YC; de Filippo E; Danish A; Lacher SK; Červinková B; Rafehi M; Fuxe K; Schiedel AC; Franco R; Müller CE
    Oncotarget; 2018 Mar; 9(17):13593-13611. PubMed ID: 29568380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A
    De Filippo E; Hinz S; Pellizzari V; Deganutti G; El-Tayeb A; Navarro G; Franco R; Moro S; Schiedel AC; Müller CE
    Biochem Pharmacol; 2020 Feb; 172():113718. PubMed ID: 31751537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
    Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
    Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modafinil exerts anti-inflammatory and anti-fibrotic effects by upregulating adenosine A
    Li H; Kim JA; Jo SE; Lee H; Kim KC; Choi S; Suh SH
    Purinergic Signal; 2024 Aug; 20(4):371-384. PubMed ID: 37938538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of heteromeric complexes between chemokine (C-X-C motif) receptor 4 and α
    Gao X; Enten GA; DeSantis AJ; Volkman BF; Gaponenko V; Majetschak M
    Biochem Biophys Res Commun; 2020 Jul; 528(2):368-375. PubMed ID: 32085899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A patent review of adenosine A
    Francucci B; Dal Ben D; Lambertucci C; Spinaci A; Volpini R; Marucci G; Buccioni M
    Expert Opin Ther Pat; 2022 Jun; 32(6):689-712. PubMed ID: 35387537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of extracellular cysteine residues in the adenosine A2A receptor.
    De Filippo E; Namasivayam V; Zappe L; El-Tayeb A; Schiedel AC; Müller CE
    Purinergic Signal; 2016 Jun; 12(2):313-29. PubMed ID: 26969588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric modulators of human A2B adenosine receptor.
    Trincavelli ML; Giacomelli C; Daniele S; Taliani S; Cosimelli B; Laneri S; Severi E; Barresi E; Pugliesi I; Greco G; Novellino E; Da Settimo F; Martini C
    Biochim Biophys Acta; 2014 Mar; 1840(3):1194-203. PubMed ID: 24361612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of NADPH oxidase in A2A adenosine receptor-mediated increase in coronary flow in isolated mouse hearts.
    Zhou Z; Rajamani U; Labazi H; Tilley SL; Ledent C; Teng B; Mustafa SJ
    Purinergic Signal; 2015 Jun; 11(2):263-73. PubMed ID: 25911169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation.
    Vecchio EA; Tan CY; Gregory KJ; Christopoulos A; White PJ; May LT
    J Pharmacol Exp Ther; 2016 Apr; 357(1):36-44. PubMed ID: 26791603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of V6.51L as a selectivity hotspot in stereoselective A
    Wang X; Jespers W; Prieto-Díaz R; Majellaro M; IJzerman AP; van Westen GJP; Sotelo E; Heitman LH; Gutiérrez-de-Terán H
    Sci Rep; 2021 Jul; 11(1):14171. PubMed ID: 34238993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function.
    Fuxe K; Ferré S; Canals M; Torvinen M; Terasmaa A; Marcellino D; Goldberg SR; Staines W; Jacobsen KX; Lluis C; Woods AS; Agnati LF; Franco R
    J Mol Neurosci; 2005; 26(2-3):209-20. PubMed ID: 16012194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Characterization of P626, a Novel Dual Adenosine A
    Venturini M; Cherchi F; Santalmasi C; Frulloni L; Dettori I; Catarzi D; Pedata F; Colotta V; Varano F; Coppi E; Pugliese AM
    Biomolecules; 2023 May; 13(6):. PubMed ID: 37371474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of endogenous A
    Goulding J; May LT; Hill SJ
    Biochem Pharmacol; 2018 Jan; 147():55-66. PubMed ID: 29106905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D-pharmacophore models for selective A2A and A2B adenosine receptor antagonists.
    Wei J; Wang S; Gao S; Dai X; Gao Q
    J Chem Inf Model; 2007; 47(2):613-25. PubMed ID: 17330954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible Antagonists for the Adenosine A
    Temirak A; Schlegel JG; Voss JH; Vaaßen VJ; Vielmuth C; Claff T; Müller CE
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosterism vs. Orthosterism: Recent Findings and Future Perspectives on A
    Barresi E; Martini C; Da Settimo F; Greco G; Taliani S; Giacomelli C; Trincavelli ML
    Front Pharmacol; 2021; 12():652121. PubMed ID: 33841166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine-stimulated adrenal steroidogenesis involves the adenosine A2A and A2B receptors and the Janus kinase 2-mitogen-activated protein kinase kinase-extracellular signal-regulated kinase signaling pathway.
    Chen YC; Huang SH; Wang SM
    Int J Biochem Cell Biol; 2008; 40(12):2815-25. PubMed ID: 18582595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of A
    Gessi S; Bencivenni S; Battistello E; Vincenzi F; Colotta V; Catarzi D; Varano F; Merighi S; Borea PA; Varani K
    Front Pharmacol; 2017; 8():888. PubMed ID: 29249971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The olfactory Olfr-78/51E2 receptor interacts with the adenosine A
    Lillo J; García-Pérez I; Lillo A; Serrano-Marín J; Martínez-Pinilla E; Navarro G; Franco R
    Front Pharmacol; 2023; 14():1108617. PubMed ID: 37266149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.